Plaquenil (Concordia Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Plaquenil drug offered from Concordia Pharmaceuticals Inc.. This Antirheumatic Agent [EPC],Antimalarial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Concordia Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Hydroxychloroquine Sulfate |
| SUBSTANCE NAME: | HYDROXYCHLOROQUINE SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antirheumatic Agent [EPC],Antimalarial [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-06-28 |
| END MARKETING DATE: | 0000-00-00 |
Plaquenil HUMAN PRESCRIPTION DRUG Details:
| Item Description | Plaquenil from Concordia Pharmaceuticals Inc. |
| LABELER NAME: | Concordia Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2013-06-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59212-562_2f9dbc94-04c9-4499-aeab-b9ef7b92563c |
| PRODUCT NDC: | 59212-562 |
| APPLICATION NUMBER: | NDA009768 |
Other HYDROXYCHLOROQUINE SULFATE Pharmaceutical Manufacturers / Labelers:
